Status:
WITHDRAWN
Hip and Knee Scoring System to Predict Complication Rate and Candidacy for Total Hip and Knee Arthroplasty
Lead Sponsor:
Rush University Medical Center
Conditions:
Osteoarthritis, Knee
Osteoarthritis, Hip
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a prospective validation study of a new hip and knee replacement-specific questionnaire that can be used to predict postoperative complications. The purpose of this study is to confirm t...
Eligibility Criteria
Inclusion
- Patients must be male or female of any race.
- Patients much be age greater than 18 years old.
- Patients undergoing a primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) by participating surgeons at this institution.
Exclusion
- Patients with history of native joint infection or active periprosthetic infection according to Musculoskeletal Infection Society (MSIS) Criteria.
- Patients requiring removal of hardware during their primary total hip arthroplasty (THA) or total knee arthroplasty (TKA).
- Patients requiring use of revision THA or TKA components (stems, augments).
- Patients with history of neuromuscular disorder impairing ability to participate in standard postoperative rehabilitation protocol
Key Trial Info
Start Date :
October 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04087304
Start Date
October 18 2018
End Date
October 25 2022
Last Update
October 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60608